Introduction
Clinical high risk (CHR) of psychosis is defined as a state in which subthreshold positive psychotic symptoms, such as perceptual abnormalities or overvalued ideas, occur, but their severity or duration fails to fulfil the criteria for a diagnosis of psychosis.1 2 Cognitive deficits are a key feature of CHR individuals and are associated with functional outcomes.3 A meta-analysis comparing CHR individuals with healthy controls (HCs) found extensive cognitive impairments in executive function, verbal and visual memory, verbal fluency, attention, working memory, and social cognition in the at-risk group.4 Findings to date strongly indicate that memory impairments are present during the premorbid phase of psychosis, and working memory impairments, in particular, are predictive of future conversion to psychosis.5 However, the underlying neurobiological mechanisms are not well understood.
Functional magnetic resonance imaging (fMRI) has been widely used to investigate neurobiological deficits in CHR. However, fMRI studies have reported inconsistent findings, with some studies reporting hyperactivation and others showing hypoactivation in the dorsal lateral prefrontal cortex (DLPFC) during working memory tasks.6 7 However, fMRI is inconvenient for many CHR subjects.
Functional near-infrared spectroscopy (fNIRS) is a recently developed, convenient, and non-invasive optical neuroimaging technology that uses changes in measured infrared light to make inferences regarding changes in the concentrations of cortical haemoglobin.8 Cortical tissue is interrogated using emitted light from either a light-emitting diode (LED) or a laser source and is measured using a light detector. The distance between each emitter and detector was fixed at 3 cm. Compared with fMRI, fNIRS is restricted to the measurement of shallow cortical activity and offers a low-cost, well-tolerated, convenient set-up and acquisition with reduced sensitivity to motion artefacts.8 More importantly, fNIRS provides a measurement of oxy-haemoglobin (oxy-Hb) and deoxy-haemoglobin (deoxy-Hb) concentrations, which are strongly correlated with fMRI signals.9 Previous research has shown that fNIRS is sensitive to differences in clinical diagnoses. Studies using fNIRS have indicated that during the verbal fluency test (VFT), patients with stable chronic schizophrenia show reduced activity and characteristic waveform patterns in the prefrontal cortex.10 A cross-sectional fNIRS study that focused on four different clinical stages of psychosis (healthy, CHR, first-episode, and chronic schizophrenia) indicated there are varying activity patterns among different prefrontal cortex (PFC) subregions.11 Brain activity in the superior temporal gyrus(STG), inferior frontal gyrus (IFG), and middle frontal gyrus (MFG) decreased with advancing clinical stages of psychosis,12 which was similar to the results of previous fMRI studies of the different clinical stages.13
In the present study, we measured brain activity in the prefrontal and temporal cortices using multichannel fNIRS measurements and assessed clinical symptoms and cognition. Our main hypotheses were that (1) CHR showed reduced brain activation compared with healthy individuals, and (2) reduced brain activity could be associated with cognitive function.